These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 11353632)

  • 1. Katanosin B and plusbacin A(3), inhibitors of peptidoglycan synthesis in methicillin-resistant Staphylococcus aureus.
    Maki H; Miura K; Yamano Y
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1823-7. PubMed ID: 11353632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tripropeptin C blocks the lipid cycle of cell wall biosynthesis by complex formation with undecaprenyl pyrophosphate.
    Hashizume H; Sawa R; Harada S; Igarashi M; Adachi H; Nishimura Y; Nomoto A
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3821-8. PubMed ID: 21628543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus Penicillin-Binding Protein 2 Can Use Depsi-Lipid II Derived from Vancomycin-Resistant Strains for Cell Wall Synthesis.
    Nakamura J; Yamashiro H; Miya H; Nishiguchi K; Maki H; Arimoto H
    Chemistry; 2013 Sep; 19(36):12104-12. PubMed ID: 23873669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis of lysobactin.
    Guzman-Martinez A; Lamer R; VanNieuwenhze MS
    J Am Chem Soc; 2007 May; 129(18):6017-21. PubMed ID: 17432854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of peptidoglycan biosynthesis by ramoplanin.
    Somner EA; Reynolds PE
    Antimicrob Agents Chemother; 1990 Mar; 34(3):413-9. PubMed ID: 2334153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation.
    Brötz H; Bierbaum G; Reynolds PE; Sahl HG
    Eur J Biochem; 1997 May; 246(1):193-9. PubMed ID: 9210483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increase of non-amidated muropeptides in the cell wall of vancomycin-resistant Staphylococcus aureus (VRSA) strain Mu50].
    Hanaki H; Labischinski H; Inaba Y; Hiramatsu K
    Jpn J Antibiot; 1998 Apr; 51(4):272-80. PubMed ID: 9644600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism?
    Brötz H; Bierbaum G; Markus A; Molitor E; Sahl HG
    Antimicrob Agents Chemother; 1995 Mar; 39(3):714-9. PubMed ID: 7793878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus.
    Zhao WH; Hu ZQ; Okubo S; Hara Y; Shimamura T
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1737-42. PubMed ID: 11353619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Brumfitt W; Salton MR; Hamilton-Miller JM
    J Antimicrob Chemother; 2002 Nov; 50(5):731-4. PubMed ID: 12407132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level oxacillin and vancomycin resistance and altered cell wall composition in Staphylococcus aureus carrying the staphylococcal mecA and the enterococcal vanA gene complex.
    Severin A; Tabei K; Tenover F; Chung M; Clarke N; Tomasz A
    J Biol Chem; 2004 Jan; 279(5):3398-407. PubMed ID: 14613936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulvinones as bacterial cell wall biosynthesis inhibitors.
    Antane S; Caufield CE; Hu W; Keeney D; Labthavikul P; Morris K; Naughton SM; Petersen PJ; Rasmussen BA; Singh G; Yang Y
    Bioorg Med Chem Lett; 2006 Jan; 16(1):176-80. PubMed ID: 16216496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidden Mode of Action of Glycopeptide Antibiotics: Inhibition of Wall Teichoic Acid Biosynthesis.
    Singh M; Chang J; Coffman L; Kim SJ
    J Phys Chem B; 2017 Apr; 121(16):3925-3932. PubMed ID: 28368603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin resistance in gram-positive cocci.
    Courvalin P
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S25-34. PubMed ID: 16323116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.
    Franchi D; Climo MW; Wong AH; Edmond MB; Wenzel RP
    Clin Infect Dis; 1999 Dec; 29(6):1566-8. PubMed ID: 10585815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Mode of Action for Plusbacin A
    O'Connor RD; Singh M; Chang J; Kim SJ; VanNieuwenhze M; Schaefer J
    J Phys Chem B; 2017 Feb; 121(7):1499-1505. PubMed ID: 28135800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the peptidoglycan of vancomycin-susceptible Enterococcus faecium.
    Patti GJ; Kim SJ; Schaefer J
    Biochemistry; 2008 Aug; 47(32):8378-85. PubMed ID: 18642854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin.
    Münch D; Engels I; Müller A; Reder-Christ K; Falkenstein-Paul H; Bierbaum G; Grein F; Bendas G; Sahl HG; Schneider T
    Antimicrob Agents Chemother; 2015 Feb; 59(2):772-81. PubMed ID: 25403671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of synthetic analogues based on the disaccharide structure of moenomycin, an inhibitor of bacterial transglycosylase.
    Baizman ER; Branstrom AA; Longley CB; Allanson N; Sofia MJ; Gange D; Goldman RC
    Microbiology (Reading); 2000 Dec; 146 Pt 12():3129-3140. PubMed ID: 11101671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Targeting of Cell Wall Precursors by Teixobactin Leads to Cell Lysis.
    Homma T; Nuxoll A; Gandt AB; Ebner P; Engels I; Schneider T; Götz F; Lewis K; Conlon BP
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6510-6517. PubMed ID: 27550357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.